|
1
|
Neogi T and Zhang Y: Epidemiology of
osteoarthritis. Rheum Dis Clin North Am. 39:1–19. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Markstedt K, Mantas A, Tournier I,
Martinez Avila H, Hagg D and Gatenholm P: 3D bioprinting human
chondrocytes with nanocellulose-alginate bioink for cartilage
tissue engineering applications. Biomacromolecules. 16:1489–1496.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cross M, Smith E, Hoy D, Nolte S, Ackerman
I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, et al:
The global burden of hip and knee osteoarthritis: Estimates from
the global burden of disease 2010 study. Ann Rheum Dis.
73:1323–1330. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang W, Nuki G, Moskowitz RW, Abramson S,
Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty
M, et al: OARSI recommendations for the management of hip and knee
osteoarthritis: Part III: Changes in evidence following systematic
cumulative update of research published through January 2009.
Osteoarthritis Cartilage. 18:476–499. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Majeed MH, Sherazi SA, Bacon D and Bajwa
ZH: Pharmacological treatment of pain in osteoarthritis: A
descriptive review. Curr Rheumatol Rep. 20(88)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wollheim FA: Current pharmacological
treatment of osteoarthritis. Drugs. 52 (Suppl 3):27–38.
1996.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chun-Lei Y: Clinical observation on
treatment of knee osteoarthritis with internal and external
therapies in Chinese medicine. Liaoning J Tradit Chin Med.
9:1744–1745. 2010.(In Chinese).
|
|
8
|
Baker CL Jr and Ferguson CM: Future
treatment of osteoarthritis. Orthopedics. 28 (Suppl 2):s227–s234.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tang L, Ding J, Zhou G and Liu Z:
LncRNAp21 promotes chondrocyte apoptosis in osteoarthritis by
acting as a sponge for miR451. Mol Med Rep. 18:5295–5301.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hu Y, Li S and Zou Y: Knockdown of lncRNA
H19 relieves LPS-induced damage by modulating miR-130a in
osteoarthritis. Yonsei Med J. 60:381–388. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Luo X, Wang J, Wei X, Wang S and Wang A:
Knockdown of lncRNA MFI2-AS1 inhibits lipopolysaccharide-induced
osteoarthritis progression by miR-130a-3p/TCF4. Life Sci.
240(117019)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li L and Zhang F: Novel long noncoding RNA
LINC01385 promotes nasopharyngeal carcinoma proliferation via the
miR-140-3p/Twist1 signaling pathway. Cell Cycle. 19:1352–1362.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xiao K, Yang Y, Bian Y, Feng B, Li Z, Wu
Z, Qiu G and Weng X: Identification of differentially expressed
long noncoding RNAs in human knee osteoarthritis. J Cell Biochem.
120:4620–4633. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang H, Li J, Shao W and Shen N: LncRNA
CTBP1-AS2 is upregulated in osteoarthritis and increases the
methylation of miR-130a gene to inhibit chondrocyte proliferation.
Clin Rheumatol. 39:3473–3478. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sun P, Wu Y, Li X and Jia Y: miR-142-5p
protects against osteoarthritis through competing with lncRNA XIST.
J Gene Med. 22(e3158)2020.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Wang J, Fang L, Ye L, Ma S, Huang H, Lan X
and Ma J: miR-137 targets the inhibition of TCF4 to reverse the
progression of osteoarthritis through the AMPK/NF-κB signaling
pathway. Biosci Rep. 40(BSR20200466)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen Y, Zhang L, Li E, Zhang G, Hou Y,
Yuan W, Qu W and Ding L: Long-chain non-coding RNA HOTAIR promotes
the progression of osteoarthritis via sponging miR-20b/PTEN axis.
Life Sci. 253(117685)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tardif G, Pelletier JP, Fahmi H, Fahmi H,
Hum D, Zhang Y, Kapoor M and Martel-Pelletier J: NFAT3 and
TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis.
Arthritis Res Ther. 15(R197)2013.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Tardif G, Hum D, Pelletier JP, Duval N and
Martel-Pelletier J: Regulation of the IGFBP-5 and MMP-13 genes by
the microRNAs miR-140 and miR-27a in human osteoarthritic
chondrocytes. BMC Musculoskelet Disord. 10(148)2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang Y, Shen S, Li Z, Li W and Weng X:
miR-140-5p affects chondrocyte proliferation, apoptosis, and
inflammation by targeting HMGB1 in osteoarthritis. Inflamm Res.
69:63–73. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang MY: Review and prospect: 2009's
annual report of Orthopaedic Trauma Society of Chinese Medical
Association. Chinese Journal of Orthopaedic Trauma. 1(3)2010.(In
Chinese).
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
De Nardo D: Toll-like receptors:
Activation, signalling and transcriptional modulation. Cytokine.
74:181–189. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang P, Zhu F, Tong Z and Konstantopoulos
K: Response of chondrocytes to shear stress: Antagonistic effects
of the binding partners Toll-like receptor 4 and caveolin-1. FASEB
J. 25:3401–3415. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY,
Oh HJ and Kim HY: The catabolic pathway mediated by toll-like
receptors in human osteoarthritic chondrocytes. Arthritis Rheum.
54:2152–2163. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schiphof D, van den Driest JJ and Runhaar
J: Osteoarthritis year in review 2017: Rehabilitation and outcomes.
Osteoarthritis Cartilage. 26:326–340. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li Q, Zhang Z, Guo S, Tang G, Lu W and Qi
X: LncRNA ANCR is positively correlated with transforming growth
factor-β1 in patients with osteoarthritis. J Cell Biochem.
120:14226–14232. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang Y, Wang F, Chen G, He R and Yang L:
LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3
axis. Cell Biosci. 9(54)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Y, Cao L, Wang Q, Huang J and Xu S:
LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging
miR-27a-3p in osteoarthritis. Artif Cells Nanomed Biotechnol.
47:1241–1247. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Herrero-Beaumont G, Perez-Baos S,
Sanchez-Pernaute O, Roman-Blas JA, Lamuedra A and Largo R:
Targeting chronic innate inflammatory pathways, the main road to
prevention of osteoarthritis progression. Biochem Pharmacol.
165:24–32. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gómez R, Villalvilla A, Largo R, Gualillo
O and Herrero-Beaumont G: TLR4 signalling in osteoarthritis-finding
targets for candidate DMOADs. Nat Rev Rheumatol. 11:159–170.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu L, Gu H, Liu H, Jiao Y, Li K, Zhao Y,
An L and Yang J: Protective effect of resveratrol against
IL-1β-induced inflammatory response on human osteoarthritic
chondrocytes partly via the TLR4/MyD88/NF-κB signaling pathway: an
‘in vitro study’. Int J Mol Sci. 15:6925–6940. 2014.PubMed/NCBI View Article : Google Scholar
|
